Literature DB >> 2943780

Percutaneous transluminal coronary angioplasty after thrombolytic therapy: a prospective controlled randomized trial.

R Erbel, T Pop, K J Henrichs, K von Olshausen, C J Schuster, H J Rupprecht, C Steuernagel, J Meyer.   

Abstract

In 162 patients with acute transmural myocardial infarction, combined intravenous and intracoronary thrombolytic therapy with streptokinase was initiated. In vessels that remained occluded, mechanical recanalization was performed with a 3F recanalization catheter (group I, n = 79) or a 4F Grüntzig balloon catheter (group II, n = 83). After reperfusion, intracoronary streptokinase was administered superselectively. After termination of streptokinase infusion, angioplasty was performed only in patients in group II. There was no difference between the groups in relation to sex, age, infarct location, creatine kinase levels and time between onset of symptoms and start of treatment. Initial coronary angiography showed an open vessel in 27 (34%) of 79 patients in group I and 21 (25%) of 83 patients in group II. The final reperfusion rate was 90% (71 of 79) in group I and 86% (71 of 83) in group II. Angioplasty was attempted in 69 of the 71 patients in group II with a success rate of 65% and an occlusion rate of 3%. During the hospital stay, reocclusion occurred in 14 (20%) of 71 patients in group I. After thrombolytic therapy, coronary luminal narrowing in group I was 75 +/- 17% in patients without and 87 +/- 6% in patients with reocclusion (p less than 0.05). In group II, reocclusion was found in 10 (14%) of 71 patients. After angioplasty, the degree of coronary stenosis in group II was reduced from 82 +/- 12 to 51 +/- 30% (p less than 0.001). Reocclusion was found in 3 (7%) of the 45 patients with successful angioplasty and in 7 (32%) of the 22 patients with unsuccessful angioplasty (p less than 0.01). Improvement in regional left ventricular function was observed only in patients from group II with anterior myocardial infarction. In conclusion, by combined medical and mechanical recanalization, the rate of coronary reperfusion can be increased and infarct time shortened, providing the possibility of full revascularization by angioplasty, with improvement of regional wall motion and reduction of the rate of reocclusion.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2943780     DOI: 10.1016/s0735-1097(86)80172-3

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  13 in total

Review 1.  The role of coronary angioplasty and stenting in acute myocardial infarction.

Authors:  A Brodison; R S More; A Chauhan
Journal:  Postgrad Med J       Date:  1999-10       Impact factor: 2.401

Review 2.  Treating myocardial infarction in the post-GUSTO era. A European perspective.

Authors:  M J de Boer; F Zijlstra
Journal:  Pharmacoeconomics       Date:  1997-10       Impact factor: 4.981

3.  Myocardial protection during surgical intervention for treatment of acute myocardial infarction.

Authors:  F Beyersdorf; G D Buckberg
Journal:  Tex Heart Inst J       Date:  1992

4.  Rescue PTCA Following Failed Thrombolysis and Primary PTCA: A Retrospective Study of Angiographic and Clinical Outcome.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

5.  [How it all started].

Authors:  H J Rupprecht; R Erbel; R Dörr
Journal:  Herz       Date:  2019-02       Impact factor: 1.443

6.  Newer interventions in myocardial infarction: do they make a difference?

Authors:  D I Peretz
Journal:  Can Fam Physician       Date:  1988-10       Impact factor: 3.275

7.  SWIFT trial of delayed elective intervention v conservative treatment after thrombolysis with anistreplase in acute myocardial infarction. SWIFT (Should We Intervene Following Thrombolysis?) Trial Study Group.

Authors: 
Journal:  BMJ       Date:  1991-03-09

Review 8.  Coronary microembolization--its role in acute coronary syndromes and interventions.

Authors:  R Erbel; G Heusch
Journal:  Herz       Date:  1999-11       Impact factor: 1.443

Review 9.  Indications for coronary angioplasty in acute myocardial ischemic syndromes.

Authors:  P J de Feyter; P W Serruys; P G Hugenholtz
Journal:  Cardiovasc Drugs Ther       Date:  1988-05       Impact factor: 3.727

10.  Efficacy of delayed percutaneous transluminal coronary angioplasty after intravenous use of streptokinase in myocardial infarction.

Authors:  R M Gagnon; M Morissette; P Laramée; G Dumont; F Sestier; G Leclerc; E Goudreau
Journal:  CMAJ       Date:  1988-09-01       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.